Cheuk Kwong LEE

Dr. Cheuk Kwong LEE

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2022 in Annals of Surgery
Verified
Journal Article
Open access
ASAryeh Shander
Aryeh Shander
HCHoward L. Corwin
Howard L. Corwin
JMJens Meier
Jens Meier
MAMichael Auerbach
Michael Auerbach
EBElvira Bisbe
Elvira Bisbe
MMManuel Muñoz
Manuel Muñoz
Background: Perioperative anemia has been associated with increased risk of red blood cell transfusion and increased morbidity and mortality after surgery. The optimal approach to the diagnosis and management of perioperative anemia is not fully established. Objective: To develop consensus recommendations for anemia management in surgical patients. Methods: An international expert panel reviewed the current evidence and developed recommendations using modified RAND Delphi methodology. Results: The panel recommends that all patients except those undergoing minor procedures be screened for anemia before surgery. Appropriate therapy for anemia should be guided by an accurate diagnosis of the etiology. The need to proceed with surgery in some patients with anemia is expected to persist. However, early identification and effective treatment of anemia has the potential to reduce the risks associated with surgery and improve clinical outcomes. As with preoperative anemia, postoperative anemia should be treated in the perioperative period. Conclusions: Early identification and effective treatment of anemia has the potential to improve clinical outcomes in surgical patients.

13 June 2020 in Vox Sanguinis
Verified
Journal Article
Open access
PDF file
EBEvan M. Bloch
Evan M. Bloch
RGRuchika Goel
Ruchika Goel
SWSilvano Wendel
Silvano Wendel
TBThierry Burnouf
Thierry Burnouf
AAArwa Z. Al‐Riyami
Arwa Z. Al‐Riyami
COCynthia So – Osman
Cynthia So – Osman
Background and objectives: COVID‐19 convalescent plasma (CCP) has been used, predominantly in high‐income countries (HICs) to treat COVID‐19; available data suggest the safety and efficacy of use. We sought to develop guidance for procurement and use of CCP, particularly in low‐ and middle‐income countries (LMICs) for which data are lacking.Materials and methods: A multidisciplinary, geographically representative group of individuals with expertise spanning transfusion medicine, infectious diseases and haematology was tasked with the development of a guidance document for CCP, drawing on expert opinion, survey of group members and review of available evidence. Three subgroups (i.e. donor, product and patient) were established based on self‐identified expertise and interest. Here, the donor and product‐related challenges are summarized and contrasted between HICs and LMICs with a view to guide related practices.Results: The challenges to advance CCP therapy are different between HICs and LMICs. Early challenges in HICs related to recruitment and qualification of sufficient donors to meet the growing demand. Antibody testing also posed a specific obstacle given lack of standardization, variable performance of the assays in use and uncertain interpretation of results. In LMICs, an extant transfusion deficit, suboptimal models of donor recruitment (e.g. reliance on replacement and paid donors), limited laboratory capacity for pre‐donation qualification and operational considerations could impede wide adoption.Conclusion: There has been wide‐scale adoption of CCP in many HICs, which could increase if clinical trials show efficacy of use. By contrast, LMICs, having received little attention, require locally applicable strategies for adoption of CCP.

4 October 2002 in Vox Sanguinis
Verified
Journal Article
Closed access
PDF file
CLCheuk Kwong LEE
Cheuk Kwong LEE
PHPak-Leung HO
Pak-Leung HO
NCN. K. Chan
N. K. Chan
AMA. Mak
A. Mak
JHJ. Hong
J. Hong
CLC. K. Lin
C. K. Lin

26 August 2016 in Vox Sanguinis
Verified
Journal Article
Closed access
PDF file
MGM. Goldman
M. Goldman
KMK. Magnussen
K. Magnussen
JGJ. Gorlin
J. Gorlin
LMLozano Miquel
Lozano Miquel
JSJ. Speedy
J. Speedy
HKH. G. Klein
H. G. Klein

8 March 2022 in Vox Sanguinis
Verified
Journal Article
Closed access
AAArwa Z. Al‐Riyami
Arwa Z. Al‐Riyami
TBThierry Burnouf
Thierry Burnouf
EWErica M. Wood
Erica M. Wood
DDDana V. Devine
Dana V. Devine
AOAdaeze Oreh
Adaeze Oreh
TGthe ISBT COVID‐19 Convalescent Plasma Working Group
the ISBT COVID‐19 Convalescent Plasma Working Group

1 September 2010 in Transfusion
Verified
Journal Article
Closed access
PDF file
HWHoi K. Wong
Hoi K. Wong
CLCheuk Kwong LEE
Cheuk Kwong LEE
Ivan FN HungIvan FN Hung
Ivan FN Hung
JLJennifer N.S. Leung
Jennifer N.S. Leung
JHJuliana Hong
Juliana Hong
CLChe K. Lin
Che K. Lin